Bimiralisib free base

Bimiralisib is an orally bioavailable pan-inhibitor of phosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) inhibitor with potential anti-tumor activity. Bimiralisib inhibits PI3K kinase isoforms alpha, beta, gamma, and delta, and to a lesser extent mTOR kinase, which may lead to tumor cell apoptosis and inhibit the growth of cells overexpressing PI3K/mTOR.

• Supplier: Alfa Cytology
• Product #: BC0128